Cundari Dominic R 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Cundari Dominic R
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2024-06-01+15,000→ 15,000 totalExercise: $2.90Exp: 2034-05-31→ Common Shares (15,000 underlying)
Holdings
- 2,800
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025.